https://www.selleckchem.com/pr....oducts/ripasudil-k-1
In light of political discussions about minimum case volumes and certified lung cancer centers, this observational study investigates differences in therapy and survival between high vs. low patient volume hospitals (HPVH vs. LPVH). We identified 12,374 lung cancer patients treated in HPVH (67 patients) and LPVH in 2013 from German health insurance claims. Stratified by metastasis status (no metastases, nodal metastases, systemic metastases), we compared HPVHs and LPVHs regarding likelihood of resection and systemic therapy,
Beğen
Yorum Yap
Paylaş
